← Evidence map

ArticleTherapeutic innovation & regulatory science2025

Verifying Clinical Benefit of New Anticancer Drugs After Regulatory Approval Based on Exploratory Studies.

Akira Ito et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 39928237